India's largest platform for AI & Analytics leaders, professionals & aspirants

Sign in

India's largest platform for AI & Analytics leaders, professionals & aspirants

3AI Digital Library

Pandemic has “fundamentally accelerated” the process of digital transformation – Satya Nadella

3AI February 1, 2021

“What we were going to think about during 2030 is probably going to be true in 2025,” Nadella added. He was speaking at the Resurgence TiEcon Delhi-NCR summit.

Picture from freepik.com

    3AI Trending Articles

  • Creating the Bridge of Translation between AI Technologists and Business

    Featured Article: Author:  Abhishek Tandon, Director, Customer Success for Fosfor, LTIMindtree Like we saw in the previous article “Crossing the AI Adoption Chasm“, there is a big gap in the objective of the technologists driving the AI project and the business user seeking value from it. This gap is causing major adoption issues as both […]

  • Importance Of Data-Centric AI In Business And The Role Of Observability In It

    Featured Article: Author:  Anirban Nandi, Vice President, AI Products & Business Analytics, Rakuten India We all have heard the old saying that “Data is the new oil”. But wait!! Is that completely true? Just like oil, unrefined data is of little to no use. So, allow me to correct the maxim a little – “Quality […]

  • Cloud4C and Google Cloud to build CoE for SAP and Anthos

    The partnership aims to enable enterprises to accelerate their digital transformation journey on the cloud. Cloud4C, a cloud managed services provider, is collaborating with Google Cloud to build a Centre of Excellence (CoE) for SAP and Anthos by Google Cloud. The center of excellence (CoE) will equip businesses with capabilities to modernize mission critical IT infrastructure and applications, while […]

  • AI in Drug Discovery

    Featured Article: Author: Vijay Morampudi, Director & Head of AI, Wavelabs Technologies Drug discovery takes 12-15 years and a median investment of nearly $1 billion to bring a new drug to market. While the true cost of research and development may be as high as $2.5 billion per marketed therapy, when factoring in abandoned trials and […]